Logo

Bayer HealthCare Renews, Extends Ariadne Software License Through 2010

Jun 18, 2007
NEW YORK (GenomeWeb News) — Ariadne yesterday said that Bayer HealthCare has renewed and expanded a licensing agreement that allows it to use the company’s Pathway Studio through 2010 for toxicology studies and microarray data analysis.
 
The Ariadne data-mining software is used to analyze pathways, signaling networks, and to interpret microarray data, the company said.
 
Ariadne also said it is developing a MedScan toxicology module that holds knowledge of small molecules and their interactions with cells and proteins, which Bayer HealthCare will use in its research.
 
Financial terms of the agreement were not released.

Filed under

Informatics
Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.